This webinar will focus on the recommendations for the 2024-25 virus season and implications of respiratory viruses on adults living with chronic medical conditions like asthma, COPD, diabetes and ...
Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...
Dupixent has been approved for CSU in Japan and the United Arab Emirates (UAE) and is also under regulatory review in the European Union based on earlier trial readouts. Outside of Japan and the UAE, ...